際際滷

際際滷Share a Scribd company logo
GIARDIASIS
M.Moghadami Internist, subspecialist of infectious disease
1
INTRODUCTION
 van Leeuwenhoek 1600
 Giardia lamblia (intestinalis and duodenalis )
1900s
 intestinal flagellates in the division Protozoa
 Human but other such as dog, cat, cow,
beaver, and sheep
2
 A common cause of epidemic and endemic
diarrhea in world
3
SPECIES
 Giardia lambelia in human
 Giardia muris ,G agilis, G microti, G psittaci
4
LIFE CYCLE: TROPHOZOITE
 freely living stage
 9 to 21 亮m long
and 5 to 15 亮m
wide
 Morphology
 Growth : biliary
lipids, a high
concentration of
cysteine, and low
oxygen tension
5
LIFE CYCLE: CYST
 smooth, oval, thin-walled
cysts 8 to 12 亮m long
and 7 to 10 亮m wide
 Encystation: cholesterol
starvation ,alkaline pH
 Excystation :gastric acid
and pancreatic enzymes
6
 Cyst resistance to cholorization
 3 month stay alive
 Production in terminal illeum
7
EPIDEMIOLOGY
 Giardia is distributed throughout the world. In
US G. lamblia has been demonstrated in 4%
to 7% of stool specimens, making it the most
commonly identified intestinal parasite.
 In resource-poor regions of the world,
Giardia is one of the first enteric pathogens
to infect infants, with peak prevalence rates
of 15% to 30% occurring in children younger
than 10 years.
8

擧悋 擧惆
3
惡慍惘擯愕悋悋 惡惘悋惡惘

悽悋 惠  惆悋惘愕  悋 擧惆擧 惆

慍惘 擧惆擧悋 惡悋惘惆悋惘 惆惘 慍悋
5
愕悋

悋愕悋 惆惘 惠悋 悽惘
9

愆惘 悛悵惘惡悋悴悋 惆惘
( :
慍悋惆 愆惘惺惠 惆擧惠惘 愀悋惺
)
6609
惠惘 愆悋惺 悋惘惆悋 惘
15/2
%
 悋惘 惆惘
43/8
%
惆 惆惘
10
110
惘愕惠悋 惆悋愆悴
(
慍悋惆 悋惡 惆擧惠惘 愀悋惺
)
8/4
%
 悋擯 惡 悛惆擯
3.9
%
惘惆悋 悋 惡 悛惆擯
悋慍惆惘悋 惘愕惠悋
:
10.2
%
悛惆擯
11
ROUTES OF INFECTION
 contaminated water : Recreational
water ,Backpackers , water treated by a
faulty purification system,
 food borne transmissions
 person-to-person :young children in
daycare centers (30-50% cyst passer)
12
PATHOGENESIS
 Infection ingestion of as few as 10 to 25
cysts
 After excystation, colonize and multiply in
the upper small bowel.
 Adherence in gut is via the ventral disk, with
attachment at the brush border of
enterocytes .
13
 Avoidance of peristalsis
 Disruption of brush border cells
 Disacharidse defeciency
 Rarely invasion,enterotoxin,..
14
GI INVOLVMENT
 Duodenum: 82.5%
 Jejunum: 2,1%
 Stomach: 8.7%
 Ileum: 12.1%
 Colon: 0.4%
15
IMMUNE RESPONSE
 Important in clearing of infection
 Prevalence in developing countries is higher
in younger ages
 Humoral immunity
 Cellular immunity
 Inflammatory response enterocytes
damage
 Human milk
16
PREDISPOSITION
 common variable immunodeficiency and in
children with X-linked agammaglobulinemia
 gastric surgery and reduced gastric acidity
 Role of HIV Infection
17
18
CLINICAL MANIFESTATIONS
19
 asymptomatic cyst passage
 acute self-limited diarrhea
 chronic syndrome of diarrhea,
malabsorption, and weight loss
 100 ingesting cysts, an 5% to 15%
asymptomatic cyst passers, 25% to 50%
symptomatic with an acute diarrheal
syndrome, and the remaining 35% to 70%
have no trace of infection.
20
ACUTE DIARRHEA
 acute onset of diarrhea, abdominal
cramps, bloating, and flatulence
 symptomatic for more than 1 week to 10
days
 severe illness
21
CHRONIC DIARRHEA
 profound malaise
 diffuse abdominal and epigastric discomfort
 Small volume ,greasy stool
 Weight loss
 Periodic diarrhea
 Malabsorption
 post-Giardia lactose intolerance
 As cause for growth retardation?
22
DIAGNOSIS
 should be considered in all patients with
prolonged diarrhea, particularly that which is
associated with malabsorption or weight loss
 OB & OP Examination:
Giardia should be identified 60% to 80% of
the time after one stool, and some report
over 90% identification after three stools
23
ANTIGEN ASSAYS
 85% to 98% sensitive and 90% to 100%
specific
 CWP-1 by ELISA, fluorescein-tagged
monoclonal antibodies ,.
24
SAMPLING OF THE DUODENAL CONTENTS
 the string test or Entero-Test (HDC
Corporation, Milpitas, CA),
 duodenal aspiration
 duodenal biopsy
25
TREATMENT
 Indication
 Drugs
 Pregnant ladies
26
PREVENTION
 proper handling and treatment of water used
for communities
 good personal hygiene on an individual basis
27
AMEBIASIS
ENTAMOEBA HISTOLYTICA
 Entamoeba species (histolytica and
dispar) close to lowest branch of
eukaryotic tree
 Although the organism was
originally thought to lack
mitochondria, nuclear-encoded
mitochondrial genes and a
remnant organelle have now been
identified.
 E. histolytica and E. dispar
trophozoites are morphologically
indistinguishable, ranging in size
from 10 to 60 亮m, with an average
of 25 亮m
 Pseudopod-forming, non-flagellated
protzoa
 Replicate by binary fission
 Most invasive parasite of the Entamoeba
group
 Only member that causes: Amebic colitis
& liver abscess
AMEBAS INTESTINALES
 Entamoeba
_E.histolytica (patogena)
_E.coli
_E.hartmani
_E.gingivalis(oral)
Ofooni1_08_Amebiasis_GiardiaInfection.pptx
 Trophozoites of Entamoeba
histolytica (Trichrome stain).
Two diagnostic
characteristics:
Two of the trophozoites have
ingested erythrocytes, and
the nuclei have typically a
small, centrally located
karyosome, as well as thin,
uniform peripheral chromatin.
Free-living E. histolytica with
Ingested RBCs
EPIDEMIOLOGY
 worldwide incidence = 0.2-10%
 estimated that 10% of worlds
population may be infected
 50 million cases of invasive amebiasis/yr
 100,000 deaths/yr
Region Infection Disease Death
Africa 85 million 10 million 10-30
thousand
Asia 300 million 20-30 million 25-50
thousand
Europe 20 million 100 million minimum
America 95 million 10 million 10-30
thousand
total 650 million 150-200
million
40-110
thousand
EPIDEMIOLOGIC RISK FACTORS
Persons with lower socioeconomic status in endemic area, including those
with Crowding
Immigrants from endemic area
Institutionalized populations, especially developmentally and cognitively impaired
Promiscuous male homosexuals
malnourished individuals at any age
acquired immunodeficiency syndrome??
TRANSMISSION
 Faeces- mouth
 Contaminated water
 Contaminated meals
 Street vendors of meals
LIFE CYCLE
 A cyst that is excreted into the environment is ingested by a human host
though a fecally contaminated product. The cyst then undergoes excystation in
the small bowel, becoming a trophozoite. The trophozoite, attaches to the
colonic mucin and then reproduces by clonal expansion, most commonly in the
cecum.
 Encystment
 cysts may survive for as long as 48 hours at 20属 to 25属 C on foods and have
been found to remain viable in sewage and natural surface water, at 4属 C, for 1
month.
PATHOGENESIS
 Adhesion (The trophozoite possesses a surface protein (lectin) that
recognizes the sugars galactose and N-acetylgalactosamine on the host
cell surface)
 Colitis results when the trophozoite penetrates the intestinal mucous
layer, which otherwise acts as a barrier to invasion by inhibiting amebic
adherence to the underlying epithelium and by slowing trophozoite
motility.
 killing of epithelial cells, neutrophils, and lymphocytes
 amoebapore, caspase 3,host inflammatory response
PATHOLOGY
 A spectrum of colonic lesions
ranging from nonspecific
thickening of the mucosa to the
classic flask-shaped ulcer may be
associated with amebic infection
 Liver abnormality :necrotic abscess
or periportal fibrosis, ascending
the portal venous system ,
proteinaceous debris rather than
white cells and is surrounded by a
rim of amebic trophozoites
invading tissue
Ofooni1_08_Amebiasis_GiardiaInfection.pptx
Ofooni1_08_Amebiasis_GiardiaInfection.pptx
HOST IMMUNITY
 IgA and IgG response to the lectin protein.
 Serum IgA antibody responses are found in subjects with asymptomatic E.
histolytica infection, but not during infection with E. dispar.
 Cell-mediated immune defense mechanisms probably have a role in limiting
invasive disease and resisting a recurrence after pharmacologic cure
 Cell-mediated responses have been described in patients with amebic liver
abscess.
CLINICAL MANIFESTATIONS
Intestinal Disease Extraintestinal Disease
Asymptomatic infection Liver abscess
Symptomatic noninvasive infection Liver abscess complicated by
Acute rectocolitis (dysentery) Peritonitis
Fulminant colitis with perforation Empyema
Toxic megacolon Pericarditis
Chronic nondysenteric colitis Lung abscess
Ameboma Brain abscess
Perianal ulceration Genitourinary disease
ASYMPTOMATIC INTESTINAL INFECTION
 Noninvasive intestinal infection may be established by confirmation of E.
histolytica in the stool in association with Hemoccult-negative stools, and
normal mucosa on colonoscopy
 In contrast to infection with E. dispar, asymptomatic infection with E.
histolytica is associated with a serum anti-amebic antibody response,
and frequently a stool antigen test will be positive .
 approximately 10% of patients will go on to manifest invasive
disease and most individuals will clear their infection within 18 months.
 Asymptomatic infection should be treated because of its potential to
progress to invasive disease.
INVASIVE INTESTINAL DISEASE
 Patients with amebic colitis typically present with a several-week history
of cramping abdominal pain, weight loss, and watery or bloody diarrhea.
The insidious onset and variable signs and symptoms make diagnosis
difficult, with fever and grossly bloody stool absent in most cases.
 Fulminant colitis : predisposition for occurring in malnourished, pregnant
women, recipients of corticosteroids, or very young patients. Such
patients are severely ill with fever, leukocytosis, profuse bloody mucoid
diarrhea, and widespread abdominal pain.
 Toxic megacolon : occurs in 0.5% of cases, and is a definite
complication of inappropriate corticosteroid therapy. Recognition is
important because these patients do not respond to drug therapy and
require colectomy
Ofooni1_08_Amebiasis_GiardiaInfection.pptx
HISTOPATHOLOGY OF A TYPICAL FLASK-
SHAPED ULCER OF INTESTINAL
AMEBIASIS
AMEBOMA:
 Segmented mass of granulation tissue in the cecum or ascending
colon
 Occurs in 0.5% to 1.5% of patients with intestinal amebiasis
 Tender palpable abdominal mass
 Concurrent amebic dysentery present in 2/3 of patients
 Apple-core lesions on barium enema study
 Lesions resolve with anti-amebic chemotherapy
 Intestinal constriction occurs in the colon in <1% of patients
EXTRAINTESTINAL AMEBIASIS
LIVER ABSCESS
 can appear concurrently with colitis, but more
frequently there is no evidence or history of
recent intestinal infection by E. histolytica.
 Liver abscess can manifest with an acute
onset (less than 10 days) with abdominal
pain and fever or subacutely , with weight
loss being prominent and less than half the
patients having fever or abdominal pain.
LABORATORY FINDINGS IN LIVER ABSCESS
 leukocytosis in 80%
 mild anemia > 50%
 elevated alkaline phosphatase 80%
 Elevated transaminase levels in more aggressive
disease, and a
 Elevation erythrocyte sedimentation rate
LIVER ABSCESS COMPLICATION
Complications of amebic liver abscess may arise from rupture
of the abscess with extension into the peritoneum, pleural
cavity, or pericardium. Extrahepatic amebic abscesses have
occasionally been described in the lung, brain, and skin and
presumably result from hematogenous spread.
Ofooni1_08_Amebiasis_GiardiaInfection.pptx
GROSS PATHOLOGY OF LIVER
CONTAINING AMEBIC ABSCESS
AMEBIC LIVER ABSCESSES
GROSS PATHOLOGY OF AMEBIC ABSCESS OF LIVER.
TUBE OF "CHOCOLATE" PUS FROM ABSCESS.
DIAGNOSIS OF INTESTINAL AMEBIASIS
 In developing countries, intestinal amebiasis is most commonly
diagnosed by identifying cysts or motile trophozoites on a saline wet
mount of a stool specimen. The drawbacks of this method include its low
sensitivity and false positive results owing to the presence of E. dispar or
E. moshkovskii infection.
 The diagnosis should ideally be based on the detection in stool of E.
histolytica specific antigen or DNA and by the presence of antiamebic
antibodies in serum.
 the trophozoites have ingested red blood cells, they may be assumed to
be E. histolytica and the patient should be treated. If, however, there is
no such distinguishing microscopic feature, a serum antibody test, stool
antigen test, or both should be utilized to confirm the diagnosis of E.
histolytica and not E. dispar infection, prior to initiation of treatment
Ofooni1_08_Amebiasis_GiardiaInfection.pptx
THERAPY OF CYST PASSER
Type Efficacy (%)
Paromomycin, 30 mg/kg/day in 3 divided
doses for 510 days
8590
Tetracycline, 250 mg qid for 10 days then
iodoquinol (Yodoxin), 650 mg tid for 20
days
95
Iodoquinol (diiodohydroxyquin, Yodoxin),
650 mg three times daily for 20 days
Ofooni1_08_Amebiasis_GiardiaInfection.pptx
Therapeutic aspiration of an amebic liver abscess
is occasionally required as an adjunct to antiparasitic
therapy. Drainage of the abscess should be considered
in patients who have no clinical response to
drug therapy within five to seven days or those with
a high risk of abscess rupture, as defined by a cavity
with a diameter of more than 5 cm or by the presence
of lesions in the left lobe.

More Related Content

Similar to Ofooni1_08_Amebiasis_GiardiaInfection.pptx (20)

Intestinal Entamoeba histolytica amebiasis - Copy.ppt
Intestinal Entamoeba histolytica  amebiasis - Copy.pptIntestinal Entamoeba histolytica  amebiasis - Copy.ppt
Intestinal Entamoeba histolytica amebiasis - Copy.ppt
MUNIRTAREEN
Small & large gut
Small & large gutSmall & large gut
Small & large gut
Rawalpindi Medical College
Cystic disease of liver
Cystic disease of liverCystic disease of liver
Cystic disease of liver
Dr.Avijit Banerjee
AMOEBIASIS & GIARDIASIS
AMOEBIASIS & GIARDIASIS AMOEBIASIS & GIARDIASIS
AMOEBIASIS & GIARDIASIS
Chandra Sekhar
Giardia lamblia
Giardia lambliaGiardia lamblia
Giardia lamblia
Crimson College of Technology (Pokhara University)
Epidemiology of AMOEBIASIS.pptx.............
Epidemiology of AMOEBIASIS.pptx.............Epidemiology of AMOEBIASIS.pptx.............
Epidemiology of AMOEBIASIS.pptx.............
Krupa Mathew
Giardia+Entamoeba
Giardia+EntamoebaGiardia+Entamoeba
Giardia+Entamoeba
Kamran Afzal, PhD.
Epidemiology of amoebiasis
Epidemiology of amoebiasisEpidemiology of amoebiasis
Epidemiology of amoebiasis
Krupa Mathew
Amebiasis in children
Amebiasis in childrenAmebiasis in children
Amebiasis in children
Azad Haleem
Amebiasis
Amebiasis Amebiasis
Amebiasis
Rajeev Khare
Yersinia entero
Yersinia enteroYersinia entero
Yersinia entero
Sanjogta Magar
Amoebiasis by datha
Amoebiasis by dathaAmoebiasis by datha
Amoebiasis by datha
B.Devadatha datha
microbiology imp. Flagellates ppt
microbiology imp. Flagellates pptmicrobiology imp. Flagellates ppt
microbiology imp. Flagellates ppt
joydeep1886
malabsorption synnnnfjjfjfjfjfnndrome.pptx
malabsorption synnnnfjjfjfjfjfnndrome.pptxmalabsorption synnnnfjjfjfjfjfnndrome.pptx
malabsorption synnnnfjjfjfjfjfnndrome.pptx
SarithaRani4
Tropical disease
Tropical diseaseTropical disease
Tropical disease
surgerymgmcri
5-DISEASES OF THE STOMACH AND DUODENUM.ppt
5-DISEASES OF THE STOMACH AND DUODENUM.ppt5-DISEASES OF THE STOMACH AND DUODENUM.ppt
5-DISEASES OF THE STOMACH AND DUODENUM.ppt
Jabbar Jasim
Liver abcess
Liver abcessLiver abcess
Liver abcess
syed ubaid
benign and malignant lesions of the intestines
benign and malignant lesions of the intestinesbenign and malignant lesions of the intestines
benign and malignant lesions of the intestines
Tashi Dolma Bodh
dysentery-201208191446.pptx bhdhdjjdjjdjdj
dysentery-201208191446.pptx bhdhdjjdjjdjdjdysentery-201208191446.pptx bhdhdjjdjjdjdj
dysentery-201208191446.pptx bhdhdjjdjjdjdj
RoopaSingh18
Amoebiasis
AmoebiasisAmoebiasis
Amoebiasis
Amal Osman
Intestinal Entamoeba histolytica amebiasis - Copy.ppt
Intestinal Entamoeba histolytica  amebiasis - Copy.pptIntestinal Entamoeba histolytica  amebiasis - Copy.ppt
Intestinal Entamoeba histolytica amebiasis - Copy.ppt
MUNIRTAREEN
AMOEBIASIS & GIARDIASIS
AMOEBIASIS & GIARDIASIS AMOEBIASIS & GIARDIASIS
AMOEBIASIS & GIARDIASIS
Chandra Sekhar
Epidemiology of AMOEBIASIS.pptx.............
Epidemiology of AMOEBIASIS.pptx.............Epidemiology of AMOEBIASIS.pptx.............
Epidemiology of AMOEBIASIS.pptx.............
Krupa Mathew
Epidemiology of amoebiasis
Epidemiology of amoebiasisEpidemiology of amoebiasis
Epidemiology of amoebiasis
Krupa Mathew
Amebiasis in children
Amebiasis in childrenAmebiasis in children
Amebiasis in children
Azad Haleem
microbiology imp. Flagellates ppt
microbiology imp. Flagellates pptmicrobiology imp. Flagellates ppt
microbiology imp. Flagellates ppt
joydeep1886
malabsorption synnnnfjjfjfjfjfnndrome.pptx
malabsorption synnnnfjjfjfjfjfnndrome.pptxmalabsorption synnnnfjjfjfjfjfnndrome.pptx
malabsorption synnnnfjjfjfjfjfnndrome.pptx
SarithaRani4
5-DISEASES OF THE STOMACH AND DUODENUM.ppt
5-DISEASES OF THE STOMACH AND DUODENUM.ppt5-DISEASES OF THE STOMACH AND DUODENUM.ppt
5-DISEASES OF THE STOMACH AND DUODENUM.ppt
Jabbar Jasim
Liver abcess
Liver abcessLiver abcess
Liver abcess
syed ubaid
benign and malignant lesions of the intestines
benign and malignant lesions of the intestinesbenign and malignant lesions of the intestines
benign and malignant lesions of the intestines
Tashi Dolma Bodh
dysentery-201208191446.pptx bhdhdjjdjjdjdj
dysentery-201208191446.pptx bhdhdjjdjjdjdjdysentery-201208191446.pptx bhdhdjjdjjdjdj
dysentery-201208191446.pptx bhdhdjjdjjdjdj
RoopaSingh18

Recently uploaded (20)

HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
PVI, PeerView Institute for Medical Education
Presentaci坦 "Projecte Benestar". MWC 2025
Presentaci坦 "Projecte Benestar". MWC 2025Presentaci坦 "Projecte Benestar". MWC 2025
Presentaci坦 "Projecte Benestar". MWC 2025
Badalona Serveis Assistencials
Endocarditis.pptx
Endocarditis.pptxEndocarditis.pptx
Endocarditis.pptx
Nandish Sannaiah
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the FutureCreatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Steve Jennings
legal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptxlegal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptx
Rishika Rawat
bacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptxbacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptx
Dauda Yahaya masani
4-PuroKalusugan 2025 DM 2025-0024 (1).pptx
4-PuroKalusugan 2025 DM 2025-0024 (1).pptx4-PuroKalusugan 2025 DM 2025-0024 (1).pptx
4-PuroKalusugan 2025 DM 2025-0024 (1).pptx
NashiedaLilangBuale
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level CurriculumSudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Dr Ovels
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLEHUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
daminipatel37
One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptxOne Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
Wahid Husein
ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...
ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...
ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...
alokksharma18
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
ABHAY INSTITUTION
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
zilkerapurbo
IMMUNO-ONCOLOGY DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINE
IMMUNO-ONCOLOGY  DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINEIMMUNO-ONCOLOGY  DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINE
IMMUNO-ONCOLOGY DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINE
RelianceNwosu
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Rehab Aboshama
Eye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptxEye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptx
KafrELShiekh University
Diabetic Ketoacidosis (DKA) & Its Management Protocol
Diabetic Ketoacidosis (DKA) & Its Management ProtocolDiabetic Ketoacidosis (DKA) & Its Management Protocol
Diabetic Ketoacidosis (DKA) & Its Management Protocol
Dr Anik Roy Chowdhury
FAO's Support Rabies Control in Bali_Jul22.pptx
FAO's Support Rabies Control in Bali_Jul22.pptxFAO's Support Rabies Control in Bali_Jul22.pptx
FAO's Support Rabies Control in Bali_Jul22.pptx
Wahid Husein
3 - 8 Priority Health aaaaaaOutcomes.pdf
3 - 8 Priority Health aaaaaaOutcomes.pdf3 - 8 Priority Health aaaaaaOutcomes.pdf
3 - 8 Priority Health aaaaaaOutcomes.pdf
NashiedaLilangBuale
3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular
Pooja Rani
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the FutureCreatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Steve Jennings
legal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptxlegal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptx
Rishika Rawat
bacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptxbacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptx
Dauda Yahaya masani
4-PuroKalusugan 2025 DM 2025-0024 (1).pptx
4-PuroKalusugan 2025 DM 2025-0024 (1).pptx4-PuroKalusugan 2025 DM 2025-0024 (1).pptx
4-PuroKalusugan 2025 DM 2025-0024 (1).pptx
NashiedaLilangBuale
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level CurriculumSudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Dr Ovels
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLEHUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
daminipatel37
One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptxOne Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
Wahid Husein
ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...
ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...
ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...
alokksharma18
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
ABHAY INSTITUTION
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
zilkerapurbo
IMMUNO-ONCOLOGY DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINE
IMMUNO-ONCOLOGY  DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINEIMMUNO-ONCOLOGY  DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINE
IMMUNO-ONCOLOGY DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINE
RelianceNwosu
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Rehab Aboshama
Eye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptxEye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptx
KafrELShiekh University
Diabetic Ketoacidosis (DKA) & Its Management Protocol
Diabetic Ketoacidosis (DKA) & Its Management ProtocolDiabetic Ketoacidosis (DKA) & Its Management Protocol
Diabetic Ketoacidosis (DKA) & Its Management Protocol
Dr Anik Roy Chowdhury
FAO's Support Rabies Control in Bali_Jul22.pptx
FAO's Support Rabies Control in Bali_Jul22.pptxFAO's Support Rabies Control in Bali_Jul22.pptx
FAO's Support Rabies Control in Bali_Jul22.pptx
Wahid Husein
3 - 8 Priority Health aaaaaaOutcomes.pdf
3 - 8 Priority Health aaaaaaOutcomes.pdf3 - 8 Priority Health aaaaaaOutcomes.pdf
3 - 8 Priority Health aaaaaaOutcomes.pdf
NashiedaLilangBuale
3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular
Pooja Rani

Ofooni1_08_Amebiasis_GiardiaInfection.pptx

  • 2. INTRODUCTION van Leeuwenhoek 1600 Giardia lamblia (intestinalis and duodenalis ) 1900s intestinal flagellates in the division Protozoa Human but other such as dog, cat, cow, beaver, and sheep 2
  • 3. A common cause of epidemic and endemic diarrhea in world 3
  • 4. SPECIES Giardia lambelia in human Giardia muris ,G agilis, G microti, G psittaci 4
  • 5. LIFE CYCLE: TROPHOZOITE freely living stage 9 to 21 亮m long and 5 to 15 亮m wide Morphology Growth : biliary lipids, a high concentration of cysteine, and low oxygen tension 5
  • 6. LIFE CYCLE: CYST smooth, oval, thin-walled cysts 8 to 12 亮m long and 7 to 10 亮m wide Encystation: cholesterol starvation ,alkaline pH Excystation :gastric acid and pancreatic enzymes 6
  • 7. Cyst resistance to cholorization 3 month stay alive Production in terminal illeum 7
  • 8. EPIDEMIOLOGY Giardia is distributed throughout the world. In US G. lamblia has been demonstrated in 4% to 7% of stool specimens, making it the most commonly identified intestinal parasite. In resource-poor regions of the world, Giardia is one of the first enteric pathogens to infect infants, with peak prevalence rates of 15% to 30% occurring in children younger than 10 years. 8
  • 9. 擧悋 擧惆 3 惡慍惘擯愕悋悋 惡惘悋惡惘 悽悋 惠 惆悋惘愕 悋 擧惆擧 惆 慍惘 擧惆擧悋 惡悋惘惆悋惘 惆惘 慍悋 5 愕悋 悋愕悋 惆惘 惠悋 悽惘 9
  • 10. 愆惘 悛悵惘惡悋悴悋 惆惘 ( : 慍悋惆 愆惘惺惠 惆擧惠惘 愀悋惺 ) 6609 惠惘 愆悋惺 悋惘惆悋 惘 15/2 % 悋惘 惆惘 43/8 % 惆 惆惘 10
  • 11. 110 惘愕惠悋 惆悋愆悴 ( 慍悋惆 悋惡 惆擧惠惘 愀悋惺 ) 8/4 % 悋擯 惡 悛惆擯 3.9 % 惘惆悋 悋 惡 悛惆擯 悋慍惆惘悋 惘愕惠悋 : 10.2 % 悛惆擯 11
  • 12. ROUTES OF INFECTION contaminated water : Recreational water ,Backpackers , water treated by a faulty purification system, food borne transmissions person-to-person :young children in daycare centers (30-50% cyst passer) 12
  • 13. PATHOGENESIS Infection ingestion of as few as 10 to 25 cysts After excystation, colonize and multiply in the upper small bowel. Adherence in gut is via the ventral disk, with attachment at the brush border of enterocytes . 13
  • 14. Avoidance of peristalsis Disruption of brush border cells Disacharidse defeciency Rarely invasion,enterotoxin,.. 14
  • 15. GI INVOLVMENT Duodenum: 82.5% Jejunum: 2,1% Stomach: 8.7% Ileum: 12.1% Colon: 0.4% 15
  • 16. IMMUNE RESPONSE Important in clearing of infection Prevalence in developing countries is higher in younger ages Humoral immunity Cellular immunity Inflammatory response enterocytes damage Human milk 16
  • 17. PREDISPOSITION common variable immunodeficiency and in children with X-linked agammaglobulinemia gastric surgery and reduced gastric acidity Role of HIV Infection 17
  • 18. 18
  • 19. CLINICAL MANIFESTATIONS 19 asymptomatic cyst passage acute self-limited diarrhea chronic syndrome of diarrhea, malabsorption, and weight loss
  • 20. 100 ingesting cysts, an 5% to 15% asymptomatic cyst passers, 25% to 50% symptomatic with an acute diarrheal syndrome, and the remaining 35% to 70% have no trace of infection. 20
  • 21. ACUTE DIARRHEA acute onset of diarrhea, abdominal cramps, bloating, and flatulence symptomatic for more than 1 week to 10 days severe illness 21
  • 22. CHRONIC DIARRHEA profound malaise diffuse abdominal and epigastric discomfort Small volume ,greasy stool Weight loss Periodic diarrhea Malabsorption post-Giardia lactose intolerance As cause for growth retardation? 22
  • 23. DIAGNOSIS should be considered in all patients with prolonged diarrhea, particularly that which is associated with malabsorption or weight loss OB & OP Examination: Giardia should be identified 60% to 80% of the time after one stool, and some report over 90% identification after three stools 23
  • 24. ANTIGEN ASSAYS 85% to 98% sensitive and 90% to 100% specific CWP-1 by ELISA, fluorescein-tagged monoclonal antibodies ,. 24
  • 25. SAMPLING OF THE DUODENAL CONTENTS the string test or Entero-Test (HDC Corporation, Milpitas, CA), duodenal aspiration duodenal biopsy 25
  • 26. TREATMENT Indication Drugs Pregnant ladies 26
  • 27. PREVENTION proper handling and treatment of water used for communities good personal hygiene on an individual basis 27
  • 29. ENTAMOEBA HISTOLYTICA Entamoeba species (histolytica and dispar) close to lowest branch of eukaryotic tree Although the organism was originally thought to lack mitochondria, nuclear-encoded mitochondrial genes and a remnant organelle have now been identified. E. histolytica and E. dispar trophozoites are morphologically indistinguishable, ranging in size from 10 to 60 亮m, with an average of 25 亮m
  • 30. Pseudopod-forming, non-flagellated protzoa Replicate by binary fission Most invasive parasite of the Entamoeba group Only member that causes: Amebic colitis & liver abscess
  • 31. AMEBAS INTESTINALES Entamoeba _E.histolytica (patogena) _E.coli _E.hartmani _E.gingivalis(oral)
  • 33. Trophozoites of Entamoeba histolytica (Trichrome stain). Two diagnostic characteristics: Two of the trophozoites have ingested erythrocytes, and the nuclei have typically a small, centrally located karyosome, as well as thin, uniform peripheral chromatin.
  • 34. Free-living E. histolytica with Ingested RBCs
  • 35. EPIDEMIOLOGY worldwide incidence = 0.2-10% estimated that 10% of worlds population may be infected 50 million cases of invasive amebiasis/yr 100,000 deaths/yr
  • 36. Region Infection Disease Death Africa 85 million 10 million 10-30 thousand Asia 300 million 20-30 million 25-50 thousand Europe 20 million 100 million minimum America 95 million 10 million 10-30 thousand total 650 million 150-200 million 40-110 thousand
  • 37. EPIDEMIOLOGIC RISK FACTORS Persons with lower socioeconomic status in endemic area, including those with Crowding Immigrants from endemic area Institutionalized populations, especially developmentally and cognitively impaired Promiscuous male homosexuals malnourished individuals at any age acquired immunodeficiency syndrome??
  • 38. TRANSMISSION Faeces- mouth Contaminated water Contaminated meals Street vendors of meals
  • 39. LIFE CYCLE A cyst that is excreted into the environment is ingested by a human host though a fecally contaminated product. The cyst then undergoes excystation in the small bowel, becoming a trophozoite. The trophozoite, attaches to the colonic mucin and then reproduces by clonal expansion, most commonly in the cecum. Encystment cysts may survive for as long as 48 hours at 20属 to 25属 C on foods and have been found to remain viable in sewage and natural surface water, at 4属 C, for 1 month.
  • 40. PATHOGENESIS Adhesion (The trophozoite possesses a surface protein (lectin) that recognizes the sugars galactose and N-acetylgalactosamine on the host cell surface) Colitis results when the trophozoite penetrates the intestinal mucous layer, which otherwise acts as a barrier to invasion by inhibiting amebic adherence to the underlying epithelium and by slowing trophozoite motility. killing of epithelial cells, neutrophils, and lymphocytes amoebapore, caspase 3,host inflammatory response
  • 41. PATHOLOGY A spectrum of colonic lesions ranging from nonspecific thickening of the mucosa to the classic flask-shaped ulcer may be associated with amebic infection Liver abnormality :necrotic abscess or periportal fibrosis, ascending the portal venous system , proteinaceous debris rather than white cells and is surrounded by a rim of amebic trophozoites invading tissue
  • 44. HOST IMMUNITY IgA and IgG response to the lectin protein. Serum IgA antibody responses are found in subjects with asymptomatic E. histolytica infection, but not during infection with E. dispar. Cell-mediated immune defense mechanisms probably have a role in limiting invasive disease and resisting a recurrence after pharmacologic cure Cell-mediated responses have been described in patients with amebic liver abscess.
  • 45. CLINICAL MANIFESTATIONS Intestinal Disease Extraintestinal Disease Asymptomatic infection Liver abscess Symptomatic noninvasive infection Liver abscess complicated by Acute rectocolitis (dysentery) Peritonitis Fulminant colitis with perforation Empyema Toxic megacolon Pericarditis Chronic nondysenteric colitis Lung abscess Ameboma Brain abscess Perianal ulceration Genitourinary disease
  • 46. ASYMPTOMATIC INTESTINAL INFECTION Noninvasive intestinal infection may be established by confirmation of E. histolytica in the stool in association with Hemoccult-negative stools, and normal mucosa on colonoscopy In contrast to infection with E. dispar, asymptomatic infection with E. histolytica is associated with a serum anti-amebic antibody response, and frequently a stool antigen test will be positive . approximately 10% of patients will go on to manifest invasive disease and most individuals will clear their infection within 18 months. Asymptomatic infection should be treated because of its potential to progress to invasive disease.
  • 47. INVASIVE INTESTINAL DISEASE Patients with amebic colitis typically present with a several-week history of cramping abdominal pain, weight loss, and watery or bloody diarrhea. The insidious onset and variable signs and symptoms make diagnosis difficult, with fever and grossly bloody stool absent in most cases. Fulminant colitis : predisposition for occurring in malnourished, pregnant women, recipients of corticosteroids, or very young patients. Such patients are severely ill with fever, leukocytosis, profuse bloody mucoid diarrhea, and widespread abdominal pain. Toxic megacolon : occurs in 0.5% of cases, and is a definite complication of inappropriate corticosteroid therapy. Recognition is important because these patients do not respond to drug therapy and require colectomy
  • 49. HISTOPATHOLOGY OF A TYPICAL FLASK- SHAPED ULCER OF INTESTINAL AMEBIASIS
  • 50. AMEBOMA: Segmented mass of granulation tissue in the cecum or ascending colon Occurs in 0.5% to 1.5% of patients with intestinal amebiasis Tender palpable abdominal mass Concurrent amebic dysentery present in 2/3 of patients Apple-core lesions on barium enema study Lesions resolve with anti-amebic chemotherapy Intestinal constriction occurs in the colon in <1% of patients
  • 52. LIVER ABSCESS can appear concurrently with colitis, but more frequently there is no evidence or history of recent intestinal infection by E. histolytica. Liver abscess can manifest with an acute onset (less than 10 days) with abdominal pain and fever or subacutely , with weight loss being prominent and less than half the patients having fever or abdominal pain.
  • 53. LABORATORY FINDINGS IN LIVER ABSCESS leukocytosis in 80% mild anemia > 50% elevated alkaline phosphatase 80% Elevated transaminase levels in more aggressive disease, and a Elevation erythrocyte sedimentation rate
  • 54. LIVER ABSCESS COMPLICATION Complications of amebic liver abscess may arise from rupture of the abscess with extension into the peritoneum, pleural cavity, or pericardium. Extrahepatic amebic abscesses have occasionally been described in the lung, brain, and skin and presumably result from hematogenous spread.
  • 56. GROSS PATHOLOGY OF LIVER CONTAINING AMEBIC ABSCESS
  • 58. GROSS PATHOLOGY OF AMEBIC ABSCESS OF LIVER. TUBE OF "CHOCOLATE" PUS FROM ABSCESS.
  • 59. DIAGNOSIS OF INTESTINAL AMEBIASIS In developing countries, intestinal amebiasis is most commonly diagnosed by identifying cysts or motile trophozoites on a saline wet mount of a stool specimen. The drawbacks of this method include its low sensitivity and false positive results owing to the presence of E. dispar or E. moshkovskii infection. The diagnosis should ideally be based on the detection in stool of E. histolytica specific antigen or DNA and by the presence of antiamebic antibodies in serum. the trophozoites have ingested red blood cells, they may be assumed to be E. histolytica and the patient should be treated. If, however, there is no such distinguishing microscopic feature, a serum antibody test, stool antigen test, or both should be utilized to confirm the diagnosis of E. histolytica and not E. dispar infection, prior to initiation of treatment
  • 61. THERAPY OF CYST PASSER Type Efficacy (%) Paromomycin, 30 mg/kg/day in 3 divided doses for 510 days 8590 Tetracycline, 250 mg qid for 10 days then iodoquinol (Yodoxin), 650 mg tid for 20 days 95 Iodoquinol (diiodohydroxyquin, Yodoxin), 650 mg three times daily for 20 days
  • 63. Therapeutic aspiration of an amebic liver abscess is occasionally required as an adjunct to antiparasitic therapy. Drainage of the abscess should be considered in patients who have no clinical response to drug therapy within five to seven days or those with a high risk of abscess rupture, as defined by a cavity with a diameter of more than 5 cm or by the presence of lesions in the left lobe.